Open Closing in a 27 days
OLS: Respiratory Disease Strategic Partnership
Descriptions
This general information notice is published to provide information about how the Office for Life Sciences (OLS), on behalf of the Department for Health and Social Care (DHSC), will be engaging interested parties to explore strategic partnership opportunities. OLS are a joint directorate between DHSC, the Department of Science, Innovation and Technology, and the Department for Business and Trade. Working with and on behalf of DHSC, OLS are seeking to engage with interested parties in sectors including – but not limited to – the pharmaceutical, MedTech, research and data sectors that can help us to improve respiratory outcomes in the UK via significant investment in data infrastructure, research and development, and clinical pathways. To support HMG’s ambition to improve respiratory outcomes in the UK, we are exploring potential future collaboration opportunities with OLS, DHSC, other organisations in the UK Health Family (including NHS England), and the Devolved Administrations to tackle a number of challenges including, but not limited to: • strengthening the UK’s data infrastructure for respiratory research, • accelerating research and development (R&D) for respiratory disease in the UK, and • optimising clinical pathways to improve early and accurate diagnosis as well as outcomes for respiratory disease in the UK. This early market engagement is for exploratory information gathering only, in that it will not result in the award of a “public contract” (within the meaning of the Procurement Act 2023). OLS will consider opportunities including financial investment as well as collaboration on a “contribution in kind” basis. This could provide the basis for interested parties to, for example, help shape approaches to UK respiratory research and data strategies, or engage in policy development. We wish to hear from interested parties who can help to support HMG’s ambition to improve respiratory outcomes in the UK, including but not limited to: • Transforming respiratory health outcomes, driving system-wide benefits and stimulating economic growth in the UK; • Enabling new expertise, insight or capacity in the design and creation of new data services, R&D pipelines and/or clinical pathways; • Bringing pharmaceutical and/or other healthcare expertise to help address priority issues in respiratory health. We are looking for interested parties who can bring: • Long-term commitment – A commitment to a long-term strategic partnership with HMG focussed on transforming health outcomes, driving system-wide benefits and stimulating economic growth across the UK. • Significant investment – Multi-million-pound financial and/or significant in-kind investment, which could include but not be limited to datasets, analytic capabilities, technical expertise, or trial infrastructure, into improving respiratory outcomes in the UK. • Relevant expertise – Access to expertise in the design and creation of new data services, R&D pipelines and/or clinical pathways or other relevant fields. Also, access to pharmaceutical and/or other healthcare expertise to help address priority issues in respiratory health. In return, OLS may: • Convene stakeholders across government, NHS, academia, the third sector and wider industry implementing bespoke governance where appropriate. • Provide investment and/or co-investment into improving respiratory outcomes across the UK. • Enable high-profile visibility through joint publicity with Government and NHS. • Consult industry partners on the policy environment around improving respiratory outcomes across the UK and more widely as relevant to the strategic partnership. For more details, please see the full Preliminary Market Engagement Notice here: https://atamis-1928.my.salesforce.com/sfc/p/0O000000rwim/a/Sr000001bRyL/XzQidxAMdULfHARsJ30bZ99noSAgCW7xwIm9xv762Ns Those wishing to participate in the engagement process should register their interest by completing and submitting the questionnaire at the following link: https://forms.office.com/Pages/ResponsePage.aspx?id=MIwnYaiRMUyMH-9N6Jc6HD5FeWMrqfNMlI-J0y-poM1UQ1BYNThIN1kzMUE3Q0ZCUDVEQUdKWUpGWS4u The closing date for responses is at 12:00pm on Monday 9 February 2026. We reserve the right not to accept responses received after this deadline.
Timeline
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
CPV Codes
73100000 - Research and experimental development services
72000000 - IT services: consulting, software development, Internet and support
33100000 - Medical equipments
85140000 - Miscellaneous health services
73200000 - Research and development consultancy services
72300000 - Data services
33600000 - Pharmaceutical products
72250000 - System and support services
85145000 - Services provided by medical laboratories
85100000 - Health services
73000000 - Research and development services and related consultancy services
Keywords
medicinal drugs
IT consulting
applied research
health promotion
web services
project roadmap
network support
cloud services
product analysis
hospital devices
R&D planning
data services
hospitalization
funding advisory
R&D services
outpatient care
policy advisory
field trials
medical services
IT outsourcing
feasibility studies
tech assistance packages
information retrieval
patient care provision
prescription medicines
lab sample processing
healthcare devices
prototype development
proposal development
software development
cybersecurity support
data asset handling
experimental design
scientific advisory
industrial consultancy
application maintenance
test implementation
genetic screening
community health support
full-cycle IT support
technology development
experimental studies
medical apparatus
development oversight
medical equipment
non-specialist care
managed systems support
biochemical analysis
pharmaceutical compounds
innovation consultancy
diagnostic services
clinical equipment
info-tech data support
scientific research
help desk services
digital transformation
laboratory testing
technology investigation
database solutions
technical support
health assessments
clinical diagnostics
development support
market relevance study
IT data solutions
innovation strategy
patient health education
discovery research
healthcare services
lab result analysis
health consultancy
pathology lab services
specialist consultations
product innovation
system integration
therapeutic treatments
software customization
innovation modeling
wellness programs
generic pharmaceuticals
IT support framework
microbiological testing
user support coverage
clinical healthcare
medical test provision
preventive health services
IT infrastructure management
commercialization consulting
electronic records management
technology trend analysis
structured data operations
public health initiatives
infrastructure maintenance
general wellbeing services
end-to-end system services
medical laboratory testing
diagnostic laboratory services
enterprise data workflows
digital information services
integrated system operations
reactive and proactive IT services
preventive health measures
active pharmaceutical ingredients
Tender Lot Details & Award Criteria
1 Tender Lots
Workflows
Status :
Procedure :
Suitable for SME :
Nationwide :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
Tenderbase ID :
Low Value :
High Value :
